Fresenius Medical Care AG
Company Profile
Business description
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.
Contact
Else-Kroener-Strasse 1
Bad HomburgHE61352
DEUT: +49 791033353
E: robert.adolph(at)fmc-ag.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2024
Employees
113,639
Stocks News & Analysis
stocks
Microsoft earnings: Strength in cloud, guidance mixed
stocks
Chart of the week: Small caps lagging
stocks
An impending merger just raised our fair value for this ASX retail giant
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,422.10 | 17.40 | -0.21% |
| CAC 40 | 7,350.37 | 77.99 | -1.05% |
| DAX 40 | 19,077.54 | 179.80 | -0.93% |
| Dow JONES (US) | 41,763.46 | 378.08 | -0.90% |
| FTSE 100 | 8,110.10 | 49.53 | -0.61% |
| HKSE | 20,317.33 | 63.31 | -0.31% |
| NASDAQ | 18,095.15 | 512.78 | -2.76% |
| Nikkei 225 | 39,081.25 | 196.14 | -0.50% |
| NZX 50 Index | 12,569.19 | 69.71 | -0.55% |
| S&P 500 | 5,705.45 | 108.22 | -1.86% |
| S&P/ASX 200 | 8,160.00 | 20.40 | -0.25% |
| SSE Composite Index | 3,279.82 | 13.59 | 0.42% |